688319 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Chengdu Olymvax Biopharmaceuticals, Inc. engages in the research and development, manufacture, and sale of human-use vaccines. The company was founded on December 11, 2009 and is headquartered in Chengdu, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688319 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company